Effects of Gentamicin-Loaded Chitosan-ZnO Nanocomposite on Quorum-Sensing Regulation of Pseudomonas Aeruginosa
- PMID: 34003434
- DOI: 10.1007/s12033-021-00336-5
Effects of Gentamicin-Loaded Chitosan-ZnO Nanocomposite on Quorum-Sensing Regulation of Pseudomonas Aeruginosa
Abstract
Cell density-based intercellular signaling mechanism is known as Quorum sensing (QS); it serves a significant role in regulating the pathogenic factors. The objective of the present study was to assess the influence of chitosan-zinc oxide nanocomposite (CH-ZnO nanocomposite), alone and in combination with gentamicin, on the sensitivity to hydrogen peroxide (H2O2), the production of pathogenic factors and QS-regulated genes of Pseudomonas aeruginosa. The efficacy of the minimum inhibitory concentration (MIC) and 1/4 MIC of the CH-ZnO nanocomposite, alone and in combination with gentamicin, on the sensitivity to H2O2, pyocyanin secretion, swarming and twitching motilities was evaluated. In addition, the expression of some QS-regulated genes including rhlI, rhlR, lasI and lasR genes was measured by Real-time quantitative PCR (RT-qPCR) following exposure to the nanocomposite. The results demonstrated that at MIC concentrations, the gentamicin-loaded CH-ZnO nanocomposite significantly inhibited QS-regulated phenotypes such as pyocyanin secretion (82.4%), swarming (76%) and twitching (73.6%) motilities; further it increased the inhibition growth zone (134.5%), as well as, at 1/4 MIC concentration decreased the expression of lasI (72%), lasR (78%), rhlI (76%) and rhlR (82%) genes; as compared to untreated P. aeruginosa PAO1 (P < 0.05). Our results also demonstrated that the CH-ZnO nanocomposite combined with gentamicin could be a potential innovative candidate, which could be broadly applied in the treatment of P. aeruginosa infections.
Keywords: Chitosan-ZnO nanocomposite; Pseudomonas aeruginosa; Quorum sensing; Virulence factors.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Chitosan and chitosan-zinc oxide nanocomposite inhibit expression of LasI and RhlI genes and quorum sensing dependent virulence factors of Pseudomonas aeruginosa.Int J Biol Macromol. 2020 Apr 15;149:1109-1117. doi: 10.1016/j.ijbiomac.2020.02.019. Epub 2020 Feb 4. Int J Biol Macromol. 2020. PMID: 32032711
-
Inhibition of Pseudomonas aeruginosa quorum sensing by subinhibitory concentrations of curcumin with gentamicin and azithromycin.J Glob Antimicrob Resist. 2017 Sep;10:21-28. doi: 10.1016/j.jgar.2017.03.006. Epub 2017 Jun 4. J Glob Antimicrob Resist. 2017. PMID: 28591665
-
The assessment of antibiofilm activity of chitosan-zinc oxide-gentamicin nanocomposite on Pseudomonas aeruginosa and Staphylococcus aureus.Int J Biol Macromol. 2020 Nov 15;163:2248-2258. doi: 10.1016/j.ijbiomac.2020.09.037. Epub 2020 Sep 11. Int J Biol Macromol. 2020. PMID: 32920055
-
Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.World J Microbiol Biotechnol. 2017 Mar;33(3):50. doi: 10.1007/s11274-016-2195-0. Epub 2017 Feb 10. World J Microbiol Biotechnol. 2017. PMID: 28188589
-
Mechanisms of the Quorum Sensing Systems of Pseudomonas aeruginosa: Host and Bacteria.Curr Med Chem. 2024;31(35):5755-5767. doi: 10.2174/0929867331666230821110440. Curr Med Chem. 2024. PMID: 37605403 Review.
Cited by
-
Gentamicin-Ascorbic Acid Encapsulated in Chitosan Nanoparticles Improved In Vitro Antimicrobial Activity and Minimized Cytotoxicity.Antibiotics (Basel). 2022 Nov 2;11(11):1530. doi: 10.3390/antibiotics11111530. Antibiotics (Basel). 2022. PMID: 36358185 Free PMC article.
References
-
- Matta, R., Hallit, S., Hallit, R., Bawab, W., Rogues, A.-M., & Salameh, P. (2018). Epidemiology and microbiological profile comparison between community and hospital acquired infections: a multicenter retrospective study in Lebanon. Journal of Infection and Public Health, 11, 405–411. - PubMed - DOI
-
- Pelgrift, R. Y., & Friedman, A. J. (2013). Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Del. Rev., 65, 1803–1815. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical